The Traderszone Network

Published in TZ Latest News 18 October, 2021 by The TZ Newswire Staff

Homology Medicines Initiates Clinical Trial for HMI-203, a One-Time Investigational Gene Therapy Candidate for Adults with MPS II (Hunter Syndrome)

– juMPStart Trial to Evaluate First Systemic Gene Therapy Candidate for Patients with Hunter Syndrome –